" class="no-js "lang="en-US"> Matt Hancock Archives - Medtech Alert
Friday, March 01, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

ReStart and Better Announce a Partnership to Improve Data Interoperability Within the NHS

ReStart and Better have signed a partnership agreement to improve interoperability between NHS organisations, regardless of […]

£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery

Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]

Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive

Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]

More than 30 Million People Vaccinated with Second Dose

More than 30 million people in the UK have been vaccinated with a second dose […]

£36 Million Boost for AI Technologies to Revolutionise NHS Care

New technology will help detect cancers and provide mental health support Projects are part of […]

Sir Richard Sykes Appointed Chair of Vaccine Taskforce

Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant […]

Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics

Life science industry leaders are joining forces with governments to step up collective efforts to […]

New UK Strategy Sets out Ambition to Be World Leaders in Organ Donation and Transplantation

Increasing consent rates for organ donation and making the most of donated organs for transplant […]

Eddie Gray Appointed Chair of Antivirals Taskforce

The UK government has appointed Eddie Gray as the new chair of the Antivirals Taskforce. […]

NHS Treats First Patient with the ‘World’s Most Expensive Drug’

A five-month old baby has become the first patient to receive a potentially life-saving drug […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more